Jaimie Meyer
Research & Publications
Biography
News
Research Summary
Dr. Meyer's lab centers on HIV and women’s health. We inform, develop and test HIV prevention and treatment interventions specific to women who are involved in carceral systems, women with substance use disorders, and women experiencing intimate partner violence. In doing so, we aim to develop interventions that address social determinants of health and are gender-responsive and trauma-informed. We apply principles of implementation science to adapt these interventions to key contexts, including carceral settings (prison, jail, probation, parole), drug treatment centers, and domestic violence service providers. Our work includes using patient-centered decision aids on HIV pre-exposure prophylaxis (PrEP) to help women make informed choices about HIV prevention, scaling up PrEP among key populations of women, and integrating housing and health services for people who are justice-involved. We strive to build programs for social justice, empowerment, and access to services to alleviate the burden of infectious diseases among key populations.
Coauthors
Research Interests
Acquired Immunodeficiency Syndrome; Epidemiologic Methods; HIV; Prisoners; Social Justice; Women's Health; Substance-Related Disorders; Biostatistics; Intimate Partner Violence; Health Equity
Public Health Interests
Epidemiology Methods; HIV/AIDS
Selected Publications
- Experience delivering an integrated service model to people with criminal justice system involvement and housing insecurityBaker O, Wellington C, Price C, Tracey D, Powell L, Loffredo S, Moscariello S, Meyer J. Experience delivering an integrated service model to people with criminal justice system involvement and housing insecurity BMC Public Health 2023, 23: 222. PMID: 36732685, PMCID: PMC9892679, DOI: 10.1186/s12889-023-15108-w.
- A PrEP Demonstration Project Using eHealth and Community Outreach to Justice-Involved Cisgender Women and Their Risk NetworksMeyer JP, Price CR, Ye Y, Qin Y, Tracey D, Demidont AC, Melbourne K, Altice FL. A PrEP Demonstration Project Using eHealth and Community Outreach to Justice-Involved Cisgender Women and Their Risk Networks AIDS And Behavior 2022, 26: 3807-3817. PMID: 35672552, DOI: 10.1007/s10461-022-03709-2.
- Overlapping needs for sexual and reproductive health and HIV prevention in women with substance use disordersGibson B, Hoff E, Haas A, Adams ZM, Price CR, Goddard-Eckrich D, Sheth SS, Dasgupta A, Meyer JP. Overlapping needs for sexual and reproductive health and HIV prevention in women with substance use disorders Women's Health 2022, 18: 17455065211070543. PMID: 35023410, PMCID: PMC8771433, DOI: 10.1177/17455065211070543.
- 87. Infectious Disease Diversity, Equity, and Antiracism (ID2EA): A Dedicated Curriculum for Infectious Disease ProfessionalsGleeson S, Bathgate M, Frederick J, Desruisseaux M, Meyer J, Virata M, Zapata H, Shenoi S, Radin J, Golden M, Trubin P, Shaw A, Friedland G, Aoun-Barakat L. 87. Infectious Disease Diversity, Equity, and Antiracism (ID2EA): A Dedicated Curriculum for Infectious Disease Professionals Open Forum Infectious Diseases 2021, 8: s55-s55. PMCID: PMC8644171, DOI: 10.1093/ofid/ofab466.087.
- Preexposure Prophylaxis for Women Across the Criminal Justice System: Implications for Policy and PracticeHoff E, Rutledge R, Gibson BA, Price CR, Gallagher C, Maurer K, Meyer JP. Preexposure Prophylaxis for Women Across the Criminal Justice System: Implications for Policy and Practice Journal Of Correctional Health Care 2021, 28: 22-31. PMID: 34762498, PMCID: PMC8825570, DOI: 10.1089/jchc.19.11.0082.
- Preference for and Efficacy of a PrEP Decision Aid for Women with Substance Use DisordersMeyer J, Price C, Tracey D, Sharpless L, Song Y, Madden L, Elwyn G, Altice F. Preference for and Efficacy of a PrEP Decision Aid for Women with Substance Use Disorders Patient Preference And Adherence 2021, 15: 1913-1927. PMID: 34511887, PMCID: PMC8420782, DOI: 10.2147/ppa.s315543.
- Chapter 11 HIV pre-exposure prophylaxis for people who inject drugsShrestha R, McCoy-Redd B, Meyer J. Chapter 11 HIV pre-exposure prophylaxis for people who inject drugs 2021, 223-236. DOI: 10.1016/b978-0-323-68328-9.00011-4.
- Predictors of Linkage to and Retention in HIV Care Following Release from Connecticut Jails and PrisonsLoeliger K, Altice F, Desai M, Ciarleglio M, Gallagher C, Meyer J. Predictors of Linkage to and Retention in HIV Care Following Release from Connecticut Jails and Prisons Open Forum Infectious Diseases 2017, 4: s38-s38. PMCID: PMC5632019, DOI: 10.1093/ofid/ofx162.092.
- Longitudinal gender differences in HIV and criminal justice outcomesMeyer J, Cepeda J, Altice F. Longitudinal gender differences in HIV and criminal justice outcomes Drug And Alcohol Dependence 2015, 146: e39-e40. DOI: 10.1016/j.drugalcdep.2014.09.479.
- Advances in the prevention of heterosexual transmission of HIV/AIDS among women in the United StatesChen N, Meyer J, Springer S. Advances in the prevention of heterosexual transmission of HIV/AIDS among women in the United States Infectious Disease Reports 2011, 3: 6. DOI: 10.4081/idr.2011.2362.
Clinical Trials
| Conditions | Study Title |
|---|---|
| Mental Health & Behavioral Research | Project CHANGE: Comprehensive Housing and Addiction Management Network for Greater New Haven |